Dr. Alex Colville joins forces with Laura Deming to lead investments in longevity science moonshots, after deploying $100M fund last year while at Stanford
age1, a venture capital firm catalyzing ...
Launch fueled by syndicate of blue-chip investors co-led by Qiming Venture Partners USA and venBio Partners
Company’s proprietary end-to-end Encompass™ platform designs enhancement-targeting chimeric (ENTAC™) molecules
Founding team ...
Startups are creating diets tailored to patients’ medical needs, betting that specially-designed foods can work as powerful weapons against disease.
Interest among venture capitalists in the medical potential of food ...
Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with ...